| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/10/2013 | WO2013067198A1 Gene signature for the prediction of nf-kappab activity |
| 05/10/2013 | WO2013067051A1 Biomarkers for tslp treatment |
| 05/10/2013 | WO2013067050A1 Genetic alterations in glioblastoma |
| 05/10/2013 | WO2013066975A1 Treatment for stabilizing nucleic acid arrays |
| 05/10/2013 | WO2013066972A1 Methods and compositions for characterizing autism spectrum disorder based on gene expression patterns |
| 05/10/2013 | WO2013066769A1 Methods of preparing lyophilized spherical-shaped pellets of biological materials |
| 05/10/2013 | WO2013066726A1 T-cell receptor clonotypes shared among ankylosing spondylitis patients |
| 05/10/2013 | WO2013066705A1 Broad detection of dengue virus serotypes |
| 05/10/2013 | WO2013066678A1 Microrna expression profiling of thyroid cancer |
| 05/10/2013 | WO2013066641A1 Colorectal cancer associated circulating nucleic acid biomarkers |
| 05/10/2013 | WO2013066144A1 Markers for ganoderma disease diagnosis and a use of thereof |
| 05/10/2013 | WO2013066039A1 Biomaterial test apparatus including a disc |
| 05/10/2013 | WO2013065957A1 Probe composition, dna chip and kit for whitefly classification, and whitefly classification method using same |
| 05/10/2013 | WO2013065944A1 Method for sequence recombination and apparatus for ngs |
| 05/10/2013 | WO2013065881A1 Apparatus and method for determining sequences of nucleic acids using atomic force microscope |
| 05/10/2013 | WO2013065770A1 Flavin-bound glucose dehydrogenase having improved substrate specificity |
| 05/10/2013 | WO2013065754A1 Detection of skin disease by caspase-14 intermediate |
| 05/10/2013 | WO2013065646A1 Method for measuring abundance of genes |
| 05/10/2013 | WO2013065623A1 Novel glucose dehydrogenase |
| 05/10/2013 | WO2013065574A1 Method for detecting target nucleic acid |
| 05/10/2013 | WO2013065499A1 Nucleic acid amplification method, nucleic acid substrate, nucleic acid analysis method, and nucleic acid analysis device |
| 05/10/2013 | WO2013065302A1 Undifferentiated cell detection method and complex carbohydrate detection method |
| 05/10/2013 | WO2013065072A1 Risk variants of prostate cancer |
| 05/10/2013 | WO2013064908A1 Methods and biomarkers for analysis of colorectal cancer |
| 05/10/2013 | WO2013064896A1 Method for identifying or detecting genomic rearrangements in a biological sample |
| 05/10/2013 | WO2013064895A1 Methods for the detection, visualization and high resolution physical mapping of genomic rearrangements in breast and ovarian cancer genes and loci brca1 and brca2 using genomic morse code in conjunction with molecular combing |
| 05/10/2013 | WO2013064834A1 Dengue assay |
| 05/10/2013 | WO2013064824A1 Methods relating to identification of susceptibilty to liver injury |
| 05/10/2013 | WO2013064789A1 Method for classifying samples of tissues that are fixed and embedded in paraffin |
| 05/10/2013 | WO2013064702A2 Probes for diagnosis and monitoring of neurodegenerative disease |
| 05/10/2013 | WO2013064641A1 Pepino mosaic virus resistant tomato plant |
| 05/10/2013 | WO2013064636A1 Combinations of molecular markers in prostate cancer providing a diagnostic tool with improved sensitivity/specificity |
| 05/10/2013 | WO2013064466A1 Fluid distribution in a sample exposure device |
| 05/10/2013 | WO2013064163A1 Methylation markers for colorectal cancer |
| 05/10/2013 | WO2013064159A1 Means and methods for assessing sperm nuclear dna structure |
| 05/10/2013 | WO2013064147A1 Genetic variants associated with cerebral malaria |
| 05/10/2013 | WO2013064066A1 Method for constructing methylated high-throughput sequencing library for whole genome and use thereof |
| 05/10/2013 | WO2013063981A1 Method for identification of non-hematogenous karyocytes enriched from body fluid of humans or animals |
| 05/10/2013 | WO2013063690A1 Dispenser and contaminant sensor |
| 05/10/2013 | WO2013063656A1 Gingipain inhibitory propeptides |
| 05/10/2013 | WO2013040491A3 Probe: antiprobe compositions for high specificity dna or rna detection |
| 05/10/2013 | WO2013040251A8 Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
| 05/10/2013 | WO2013040071A3 Sperm protein as a detection biomarker of early stage ovarian cancer |
| 05/10/2013 | WO2013039778A3 Devices with a fluid transport nanochannel intersected by a fluid sensing nanochannel and related methods |
| 05/10/2013 | WO2013039327A3 Method for screening inhibitor for expression or activity of alcohol dehydrogenase of streptococcus pneumoniae |
| 05/10/2013 | WO2013033647A3 Apparatus and method for electrical detection of oligonucleotides through pore blockades |
| 05/10/2013 | WO2013030326A3 Labeled phosphatases for the screening of inhibitors |
| 05/10/2013 | WO2013029631A3 Enzyme detection by microfluidics |
| 05/10/2013 | WO2013028554A3 Gene signatures for lung cancer prognosis and therapy selection |
| 05/10/2013 | WO2013027977A3 Composition for breaking down l-asparagine comprising l-asparaginase, and production method for l-asparaginase |
| 05/10/2013 | WO2013025773A3 Molecular markers associated with soybean root-knot nematode tolerance and methods of their use |
| 05/10/2013 | WO2013024175A3 Diagnostic means and methods for type 2 diabetes |
| 05/10/2013 | WO2013023212A3 Procurement of placental stem cells |
| 05/10/2013 | WO2013023211A3 Envelope and procurement stand for placental transport and stem cell collection |
| 05/10/2013 | WO2013023198A3 Rapid and sensitive detection of bacteria in blood products, urine, and other fluids |
| 05/10/2013 | WO2013022953A3 Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof |
| 05/10/2013 | WO2013020019A3 Hypoxia-related gene signatures for cancer classification |
| 05/10/2013 | WO2013016673A3 Use of dpep1 and tpx2 expression for evaluating treatment or survival time of patients with pancreatic ductal adenocarcinoma |
| 05/10/2013 | WO2013012440A3 Methods and devices for dna sequencing and molecular diagnostics |
| 05/10/2013 | WO2013009809A3 A method of determining the prognosis of hepatocellular carcinomas using a multigene signature associated with metastasis |
| 05/10/2013 | WO2013006793A3 Direct amplification and detection of viral and bacterial pathogens |
| 05/10/2013 | WO2013003849A3 Process and apparatus for quantifying nucleic acid in a sample |
| 05/10/2013 | WO2013002750A3 Determining tumor origin |
| 05/10/2013 | WO2012167086A3 Methods of diagnosing and treating amyotrophic lateral sclerosis |
| 05/10/2013 | WO2012153187A4 Markers for cancer prognosis and therapy and methods of use |
| 05/10/2013 | CA2857308A1 Method for detecting target nucleic acid |
| 05/10/2013 | CA2854459A1 Novel chemistry used in biosensors |
| 05/10/2013 | CA2853943A1 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/10/2013 | CA2853829A1 Evaluation and improvement of nuclease cleavage specificity |
| 05/10/2013 | CA2853816A1 Methods of preparing lyophilized spherical-shaped pellets of biological materials |
| 05/10/2013 | CA2853760A1 Methods and biomarkers for analysis of colorectal cancer |
| 05/10/2013 | CA2853745A1 Combinations of molecular markers in prostate cancer providing a diagnostic tool with improved sensitivity/specificity |
| 05/10/2013 | CA2853464A1 Undifferentiated cell detection method and complex carbohydrate detection method |
| 05/10/2013 | CA2853292A1 Transgenic pig models of cystic fibrosis |
| 05/10/2013 | CA2853194A1 Pepino mosaic virus resistant tomato plant |
| 05/10/2013 | CA2852098A1 Colorectal cancer associated circulating nucleic acid biomarkers |
| 05/09/2013 | US20130117877 Methods for determining fitness in plants |
| 05/09/2013 | US20130116499 Method for producing embryos by in vitro culture, and method, apparatus, and system for selecting embryos |
| 05/09/2013 | US20130116344 Nucleic acids and methods for detecting turfgrass pathogenic fungi |
| 05/09/2013 | US20130116303 Antagonists of miRNA-29 Expression and Their Use in the Prevention and Treatment of Aneurysm |
| 05/09/2013 | US20130116280 Fusion protein comprising C-terminal domain of RET protein and use thereof as a diagnosing marker |
| 05/09/2013 | US20130116184 RFamide-Related Peptides and Methods Thereof |
| 05/09/2013 | US20130116166 Biomarkers for idiopathic pulmonary fibrosis |
| 05/09/2013 | US20130116154 Method and substances for isolation and detection of small polynucleotides |
| 05/09/2013 | US20130116150 Lung Cancer Biomarkers and Uses Thereof |
| 05/09/2013 | US20130116149 Genetic Markers Associated with Intellectual Disability |
| 05/09/2013 | US20130116147 Dna methylation biomarkers for lung cancer |
| 05/09/2013 | US20130116145 Diagnosis and prognosis of breast cancer patients |
| 05/09/2013 | US20130116144 Methylation marker for diagnosis of cervical cancer |
| 05/09/2013 | US20130116143 Detection and analysis of epigenetic and genetic changes in tumor tissue |
| 05/09/2013 | US20130116141 Systems and Methods for Multiplex Analysis of PCR in Real Time |
| 05/09/2013 | US20130116139 Innate immunity markers of cancer |
| 05/09/2013 | US20130116136 Probes for genotyping low-risk-hpv |
| 05/09/2013 | US20130116134 Method and kit for the classification and prognosis of wounds |
| 05/09/2013 | US20130116130 Digital Counting of Individual Molecules by Stochastic Attachment of Diverse Label-Tags |
| 05/09/2013 | US20130116129 Method for detecting target molecules |
| 05/09/2013 | US20130116127 Breast cancer associated circulating nucleic acid biomarkers |
| 05/09/2013 | US20130116126 Compositions and methods for identifying and modifying carbonaceous compositions |
| 05/09/2013 | US20130115718 Carrier Carrying Identifying Information for Identifying an Identification Subject and Use Thereof |
| 05/09/2013 | US20130115687 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |